Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00055705
What this trial is testing

PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT00499694
What this trial is testing

Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 31
Testing effectiveness (Phase 2)Ended earlyNCT01308294
What this trial is testing

Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients

Who this might be right for
Melanoma
Centre Hospitalier Universitaire Vaudois 16
Post-approval studies (Phase 4)UnknownNCT01908556
What this trial is testing

Evaluation of Predictive Factors Regarding the Effectivity of Aromatase Inhibitor Therapy (PreFace)

Who this might be right for
is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients.
Institut fuer Frauengesundheit 3,545
Early research (Phase 1)Study completedNCT00081237
What this trial is testing

OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 15
Large-scale testing (Phase 3)Study completedNCT00002777
What this trial is testing

Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 342
Testing effectiveness (Phase 2)Study completedNCT00054028
What this trial is testing

Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast Cancer

Who this might be right for
Recurrent Breast CancerStage IIIB Breast CancerStage IV Breast Cancer
National Cancer Institute (NCI) 31
Testing effectiveness (Phase 2)Study completedNCT01404936
What this trial is testing

Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 35
Early research (Phase 1)Study completedNCT00006044
What this trial is testing

Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT05912244
What this trial is testing

IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 43
Testing effectiveness (Phase 2)Study completedNCT01827111
What this trial is testing

Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 21
Testing effectiveness (Phase 2)Looking for participantsNCT07226544
What this trial is testing

Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer

Who this might be right for
Localized Clear Cell Renal Cell CarcinomaResectable Clear Cell Renal Cell CarcinomaStage II Renal Cell Cancer AJCC v8+2 more
City of Hope Medical Center 31
Testing effectiveness (Phase 2)Study completedNCT00054457
What this trial is testing

Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction

Who this might be right for
Esophageal CancerGastric Cancer
Alliance for Clinical Trials in Oncology 46
Early research (Phase 1)Ended earlyNCT01529307
What this trial is testing

First in Human Trial of TAS266 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Novartis Pharmaceuticals 6
Early research (Phase 1)Study completedNCT01497392
What this trial is testing

Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers

Who this might be right for
Adenocarcinoma of the PancreasStage III Pancreatic CancerStage IV Pancreatic Cancer+1 more
Roswell Park Cancer Institute 26
Testing effectiveness (Phase 2)Study completedNCT01750281
What this trial is testing

Assess Efficacy and Safety of AZD6244 in Combination With Docetaxel in Patients Receiving Second Line Non Small Cell Lung Cancer Treatment.

Who this might be right for
Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
AstraZeneca 212
Testing effectiveness (Phase 2)Study completedNCT00005861
What this trial is testing

Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
Gynecologic Oncology Group
Early research (Phase 1)Study completedNCT00008294
What this trial is testing

Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00002466
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer

Who this might be right for
Kidney CancerSarcoma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT00242931
What this trial is testing

Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute
Next Page